Article · Volume 46, Issue 3 · pp. 290–295
An Analysis of Adequacy of Indian Drugs Regulatory Provisions in Combating the Problem of Spurious and Adulterated Drugs
B.L. Das1, Gupta R.N.2, A.K. Dorle3
- 1DInspector of Drugs, Directorate, Drugs Control, Government of Jharkhand
- 2Associate Professor, B.I.T. Mesra, Ranchi
- 3Professor Emeritus, Department of Pharmaceutical Sciences, Nagpur University
Abstract
In 2003, Mashelkar committee found that 10% of available drugs in India are Sub- standard. Recently (June 2011) Honorable Apex Court of India observed that the Drugs Act of India does not has deterrence. It has to be analyzed that whether mere enhancing the punishment under the Act shall make it deterrent. It has to be find out what other changes in the Act is required to make it more effective. Drugs Control Authorities need power of interrogation and power to ask a person to make statement. These powers shall help them to gather evidence against the culprit and these powers shall enable them to conclude the investigation to a logical end.
Keywords: Glipizide; Floating Beads; Gas forming agents; Multiple-unit Floating Drug Delivery System
The full text of this article is available as a PDF. Open the PDF.